109 related articles for article (PubMed ID: 1614281)
1. 4-Iodotomoxetine: a novel ligand for serotonin uptake sites.
Kung MP; Chumpradit S; Billings J; Kung H
Life Sci; 1992; 51(2):95-106. PubMed ID: 1614281
[TBL] [Abstract][Full Text] [Related]
2. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
D'Amato RJ; Largent BL; Snowman AM; Snyder SH
J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
[TBL] [Abstract][Full Text] [Related]
3. [125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytryptamine uptake complex. I. In vitro studies.
Mathis CA; Taylor SE; Biegon A; Enas JD
Brain Res; 1993 Aug; 619(1-2):229-35. PubMed ID: 8374781
[TBL] [Abstract][Full Text] [Related]
4. Characterization of [3H]paroxetine binding to rat cortical membranes.
Habert E; Graham D; Tahraoui L; Claustre Y; Langer SZ
Eur J Pharmacol; 1985 Nov; 118(1-2):107-14. PubMed ID: 2935409
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
6. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
[TBL] [Abstract][Full Text] [Related]
7. Comparison of (R)-[3H]tomoxetine and (R/S)-[3H]nisoxetine binding in rat brain.
Gehlert DR; Schober DA; Gackenheimer SL
J Neurochem; 1995 Jun; 64(6):2792-800. PubMed ID: 7760060
[TBL] [Abstract][Full Text] [Related]
8. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
Ge J; Barnes JM; Towers P; Barnes NM
Eur J Pharmacol; 1997 Aug; 332(3):307-12. PubMed ID: 9300265
[TBL] [Abstract][Full Text] [Related]
9. Iodinated tomoxetine derivatives as selective ligands for serotonin and norepinephrine uptake sites.
Chumpradit S; Kung MP; Panyachotipun C; Prapansiri V; Foulon C; Brooks BP; Szabo SA; Tejani-Butt S; Frazer A; Kung HF
J Med Chem; 1992 Nov; 35(23):4492-7. PubMed ID: 1447750
[TBL] [Abstract][Full Text] [Related]
10. Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.
Hewlett WA; Trivedi BL; Zhang ZJ; de Paulis T; Schmidt DE; Lovinger DM; Ansari MS; Ebert MH
J Pharmacol Exp Ther; 1999 Jan; 288(1):221-31. PubMed ID: 9862774
[TBL] [Abstract][Full Text] [Related]
11. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue.
Bäckström I; Bergström M; Marcusson J
Brain Res; 1989 May; 486(2):261-8. PubMed ID: 2525060
[TBL] [Abstract][Full Text] [Related]
12. Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.
Rothman RB; Silverthorn ML; Baumann MH; Goodman CB; Cadet JL; Matecka D; Rice KC; Carroll FI; Wang JB; Uhl GR
J Pharmacol Exp Ther; 1995 Jul; 274(1):385-95. PubMed ID: 7616423
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the binding of 3H-norzimeldine, a 5-HT uptake inhibitor, to rat brain homogenates.
Hall H
Acta Pharmacol Toxicol (Copenh); 1984 Jul; 55(1):33-40. PubMed ID: 6235721
[TBL] [Abstract][Full Text] [Related]
14. Characterization of [3H]paroxetine binding in rat brain.
Marcusson JO; Bergström M; Eriksson K; Ross SB
J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
[TBL] [Abstract][Full Text] [Related]
15. [125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytryptamine uptake complex. II. In vivo studies in rats.
Biegon A; Mathis CA; Hanrahan SM; Jagust WJ
Brain Res; 1993 Aug; 619(1-2):236-46. PubMed ID: 8374782
[TBL] [Abstract][Full Text] [Related]
16. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.
Plenge P; Mellerup ET; Laursen H
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):61-72. PubMed ID: 2137251
[TBL] [Abstract][Full Text] [Related]
17. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
Ransom RW; Asarch KB; Shih JC
J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic localization of 5HT2 receptors in rat brain using [125I]-DOI, a selective psychotomimetic radioligand.
Nazarali AJ; McKenna DJ; Saavedra JM
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):573-81. PubMed ID: 2748882
[TBL] [Abstract][Full Text] [Related]
19. In vivo labeling of serotonin uptake sites with [3H]paroxetine.
Scheffel U; Hartig PR
J Neurochem; 1989 May; 52(5):1605-12. PubMed ID: 2523469
[TBL] [Abstract][Full Text] [Related]
20. High-affinity [3H]6-nitroquipazine binding sites in rat brain.
Hashimoto K; Goromaru T
Eur J Pharmacol; 1990 May; 180(2-3):273-81. PubMed ID: 1694774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
